Activated DDR1 increases RS cell survival

Blood

Volumn 122, Issue 26, 2013, Pages 4152-4154

  Carbone, Antonino ^a   Gloghini, Annunziata ^b  

^a CENTRO DI RIFERIMENTO ONCOLOGICO   (Italy)

^b Istituto Nazionale dei Tumori   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ACTIN; CD40 ANTIGEN; COLLAGEN TYPE 1; COLLAGEN TYPE 3; COLLAGEN TYPE 4; DISCOIDIN DOMAIN RECEPTOR 1; INTEGRIN; INTERFERON; LATENT MEMBRANE PROTEIN 1; TYROSINE KINASE RECEPTOR; UNCLASSIFIED DRUG;

CELL SURVIVAL; EXTRACELLULAR MATRIX; GERMINAL CENTER; HUMAN; IN VITRO STUDY; NASOPHARYNX CARCINOMA; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; REED STERNBERG CELL; REVIEW; TUMOR MICROENVIRONMENT; UPREGULATION;

EID: 84891286163     PISSN: 00064971     EISSN: 15280020     Source Type: Journal    
DOI: 10.1182/blood-2013-11-534123     Document Type: Review

References (10)

1. Cader FZ, Vockerodt M, Bose S, et al. The EBV oncogene LMP1 protects lymphoma cells from cell death through the collagen-mediated activation of DDR1. Blood. 2013;122(26): 4237-4245.
2. Valiathan RR, Marco M, Leitinger B, Kleer CG, Fridman R. Discoidin domain receptor tyrosine kinases: new players in cancer progression. Cancer Metastasis Rev. 2012;31(1-2): 295-321.
3. Vogel W, Gish GD, Alves F, Pawson T. The discoidin domain receptor tyrosine kinases are activated by collagen. Mol Cell. 1997;1(1): 13-23. (Pubitemid 127376389)
4. Xu H, Raynal N, Stathopoulos S, Myllyharju J, Farndale RW, Leitinger B. Collagen binding specificity of the discoidin domain receptors: binding sites on collagens II and III and molecular determinants for collagen IV recognition by DDR1. Matrix Biol. 2011;30(1): 16-26.
5. Das S, Ongusaha PP, Yang YS, Park JM, Aaronson SA, Lee SW. Discoidin domain receptor 1 receptor tyrosine kinase induces cyclooxygenase-2 and promotes chemoresistance through nuclear factor-kappaB pathway activation. Cancer Res. 2006;66(16): 8123-8130. (Pubitemid 44299179)
6. Carbone A, Gloghini A, Gattei V, et al. Expression of functional CD40 antigen on Reed-Sternberg cells and Hodgkin's disease cell lines. Blood. 1995;85(3): 780-789.
7. Aldinucci D, Gloghini A, Pinto A, De Filippi R, Carbone A. The classical Hodgkin's lymphoma microenvironment and its role in promoting tumour growth and immune escape. J Pathol. 2010;221(3): 248-263.
8. Meckes DG Jr, Shair KH, Marquitz AR, Kung CP, Edwards RH, Raab-Traub N. Human tumor virus utilizes exosomes for intercellular communication. Proc Natl Acad Sci USA. 2010;107(47): 20370-20375.
9. Meckes DG Jr, Gunawardena HP, Dekroon RM, et al. Modulation of B-cell exosome proteins by gamma herpesvirus infection. Proc Natl Acad Sci USA. 2013; 110(31):E2925-E2933.
10. Celegato M, Borghese C, Casagrande N, Carbone A, Colombatti A, Aldinucci D. Bortezomib downmodulates the survival factor IRF4 in Hodgkin lymphoma cell lines and decreases the protective activity of Hodgkin lymphoma-Associated Fibroblasts [published online ahead of print May 6, 2013]. Leuk Lymphoma.